SUNWELS Co.,Ltd. (9229) AI Stock Analysis

• Market Cap: ¥26.06B
• Dividend Yield: 2.67%
• Average Volume (3M): 265.85K
• Price to Earnings (P/E): 159.7
• Beta (1Y): 1.03
• Revenue Growth: 20.41%
• EPS Growth: -251.04%
• Country: JP
• Employees: 2,435
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Care Facilities
• EPS (TTM): -22.35
• Shares Outstanding: 35,220,000
• 10 Day Avg. Volume: 128,570
• 30 Day Avg. Volume: 265,850
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥721.00
• Price Target Upside: -1.37% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 47 Neutral
• Price Target: ¥721.00 ▼(-1.37% Downside)

The overall stock score is primarily impacted by financial performance challenges, including high leverage and negative net income. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to a negative P/E ratio and lack of dividend yield. These factors collectively suggest caution for potential investors.

SUNWELS Co.,Ltd. Business Overview & Revenue Model

Company Description

SUNWELS Co., Ltd. (9229) is a leading provider in the renewable energy sector, specializing in the development and manufacturing of advanced solar energy solutions. The company focuses on innovative technologies that enhance solar panel efficiency and energy storage systems. SUNWELS operates primarily in the clean energy market, offering a range of products including solar panels, inverters, and energy management systems designed for residential, commercial, and industrial applications.

How the Company Makes Money

SUNWELS Co., Ltd. generates revenue primarily through the sale of its solar energy products, including solar panels and inverters, which are sourced from various suppliers and manufactured in-house. The company also earns income from energy storage solutions and related services, such as installation and maintenance. Key revenue streams include direct sales to consumers, partnerships with renewable energy developers, and government contracts for solar energy projects. Additionally, SUNWELS benefits from strategic collaborations with technology firms to enhance product offerings and expand market reach, contributing significantly to its earnings.

SUNWELS Co.,Ltd. Financial Statement Overview

Summary

SUNWELS Co.,Ltd. demonstrates strong revenue growth but faces profitability and cash flow challenges. High leverage and negative net income in 2025 are key concerns. The company needs to focus on improving operational efficiency and managing debt levels to enhance financial stability.

Income Statement

SUNWELS Co.,Ltd. has shown significant revenue growth over the years, with a notable increase from 2020 to 2025. However, the company is facing challenges in profitability, as indicated by a negative net profit margin in 2025. The gross profit margin has decreased over time, and the EBIT and EBITDA margins have also shown volatility, reflecting operational inefficiencies.

Balance Sheet

The company has a high debt-to-equity ratio, indicating significant leverage, which poses a risk. The return on equity has been inconsistent, with a negative ROE in 2025 due to negative net income. The equity ratio has improved over the years, suggesting a gradual strengthening of the equity base relative to total assets.

Cash Flow

SUNWELS Co.,Ltd. has experienced fluctuations in free cash flow, with negative free cash flow in recent years, highlighting cash management challenges. The operating cash flow to net income ratio is strong, indicating good cash generation relative to reported earnings. However, the free cash flow to net income ratio is concerning due to negative free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	26.50B	26.50B	21.36B	13.72B	8.42B	5.40B
Gross Profit	4.92B	4.92B	6.42B	3.75B	2.11B	1.38B
EBITDA	1.06B	1.88B	4.35B	1.45B	819.00M	562.83M
Net Income	-925.00M	-925.00M	802.00M	784.00M	255.71M	241.42M
Balance Sheet
Total Assets	38.99B	38.99B	31.52B	19.21B	9.02B	4.79B
Cash, Cash Equivalents and Short-Term Investments	5.64B	5.64B	3.31B	2.61B	814.76M	496.36M
Total Debt	22.49B	22.49B	20.11B	11.20B	6.60B	3.03B
Total Liabilities	30.37B	30.37B	24.38B	13.84B	8.15B	4.09B
Stockholders Equity	8.62B	8.62B	7.14B	4.61B	864.74M	693.47M
Cash Flow
Free Cash Flow	0.00	-2.32B	-2.94B	-741.00M	-78.18M	-392.99M
Operating Cash Flow	0.00	1.88B	2.56B	1.14B	378.19M	201.03M
Investing Cash Flow	0.00	-4.40B	-5.66B	-2.04B	-633.05M	-648.06M
Financing Cash Flow	0.00	4.84B	3.80B	2.70B	573.26M	489.42M

SUNWELS Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 731.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9229, the sentiment is Negative. The current price of 731 is below the 20-day moving average (MA) of 793.35, below the 50-day MA of 742.42, and above the 200-day MA of 662.78, indicating a neutral trend. The MACD of -10.07 indicates Positive momentum. The RSI at 41.95 is Neutral, neither overbought nor oversold. The STOCH value of 25.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9229.

SUNWELS Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2374	78 Outperform	¥20.53B	11.73		3.65%	4.31%	-9.01%
7133	71 Outperform	¥9.39B	13.35		1.51%	18.30%	37.13%
6059	68 Neutral	¥6.42B	2.92		3.01%	0.92%	1344.43%
6557	67 Neutral	¥10.40B	29.97		―	11.69%	-38.92%
7061	66 Neutral	¥11.12B	20.61		1.14%	20.37%	-5.97%
Sector *	51 Neutral	$7.93B	-0.32	-43.43%	2.21%	22.30%	-1.88%
9229	47 Neutral	¥26.06B	159.73		2.67%	20.41%	-251.04%

SUNWELS Co.,Ltd. Corporate Events

Sunwels Co., Ltd. Reports Q1 FY 2026 Financial Results with Focus on Healthcare Initiatives

Sunwels Co., Ltd. has announced its financial results for the first quarter of FY March 2026, highlighting its commitment to addressing healthcare challenges through initiatives like the ‘PD House’ for Parkinson’s disease. This strategic focus is expected to enhance the company’s positioning in the healthcare sector and contribute to societal sustainability.

SUNWELS Co.,Ltd. Reports First Quarter Loss Amidst Financial Challenges

SUNWELS Co.,Ltd. reported a challenging first quarter for the fiscal year ending June 30, 2025, with a net loss of ¥725 million, a significant decline from the previous year’s profit. The company’s financial position weakened with a decrease in net assets and equity ratio, and no dividends were declared. Despite the setback, the company maintains its sales forecast for the full year, indicating a cautious optimism about future performance.

Sunwels Co., Ltd. Announces FY March 2025 Financial Highlights and Healthcare Initiatives

Sunwels Co., Ltd. is focusing on addressing societal challenges in healthcare and caregiving by establishing specialized facilities like the ‘PD House’ for Parkinson’s disease, aiming for a sustainable society. The company announced its financial highlights for the fiscal year ending March 2025, emphasizing its commitment to healthcare innovation and sustainability, which may enhance its industry positioning and stakeholder value.

SUNWELS Co.,Ltd. Reports Increased Sales but Declining Profits for FY 2025

SUNWELS Co.,Ltd. reported its non-consolidated financial results for the year ending March 31, 2025, showing a significant increase in net sales by 31.8% to 26,496 million yen. However, the company faced a substantial decline in profitability, with operating profit falling by 51.0% and ordinary profit decreasing by 77.4%, resulting in a net loss of 925 million yen. The financial results indicate challenges in maintaining profitability despite increased sales, and the company has decided not to issue dividends for the year. This financial performance could impact its market positioning and stakeholder confidence.